Paul Silber

Paul Silber is a founding partner at Blu Venture Investors, where he has been instrumental in identifying and supporting early-stage technology companies. Before his venture capital career, he was the president and CEO of In Vitro Technologies, Inc., a company he launched and grew for 15 years before successfully selling it in 2006. His experience in building a business-to-business technology company has equipped him with a strong background in innovation and strategic execution, leading to a proven track record as an investor in over 50 Mid-Atlantic companies, focusing on sectors like enterprise SaaS, cybersecurity, IoT, and medical devices.12

Silber holds a Ph.D. in toxicology and a Master of Science in Public Health. He is also a named inventor on five patents. His investment philosophy emphasizes the importance of thorough evaluation, as he often reviews hundreds of pitches to find a few standout opportunities.12 In addition to his role at Blu Ventures, he serves on the boards or as an advisor for several organizations, including Evergreen Advisors LLC and the University of Maryland Momentum Fund.1